|
MDA-MB-231 cells
|
8.0/8.4 mM
|
MTS and trypan blue assays
|
Download PDF
|
|
EMT6 breast cancer cells
|
5 mmol/L
|
CCK-8 assays
|
Download PDF
|
|
4T1 breast cancer cells
|
5 mmol/L
|
CCK-8 assays
|
Download PDF
|
|
MDA-MB-231 cells
|
8.0/8.4 mM
|
MTS and trypan blue assays
|
Download PDF
|
|
EMT6 cells
|
5 mmol/L
|
CCK-8 assays
|
Download PDF
|
|
4T1 cells
|
5 mmol/L
|
CCK-8 assays
|
Download PDF
|
|
MCF7 and MDA-MB-231
|
50 mM
|
MTT assay
|
Download PDF
|
|
MCF7 and MDA-MB-231
|
50 mM
|
MTT assay
|
Download PDF
|
|
U-251
|
5 mM
|
MTS assay
|
Download PDF
|
|
U-87
|
5 mM
|
MTS assay
|
Download PDF
|
|
CAL27 cells
|
324.4 μM
|
D-[14C]-glucose competition assay
|
Download PDF
|
|
T24
|
1.02 mM (24h), 0.51 mM (48h), 0.25 mM (72h)
|
sulforhodamine B assay
|
Download PDF
|
|
HT1376
|
5.13 mM (24h), 1.02 mM (48h), 0.51 mM (72h)
|
sulforhodamine B assay
|
Download PDF
|
|
KU1919
|
0.51 mM (24h), 0.25 mM (48h), 0.12 mM (72h)
|
sulforhodamine B assay
|
Download PDF
|
|
HT1376
|
5.13 mM (72h, 2DG monotherapy)
|
sulforhodamine B assay
|
Download PDF
|
|
HT1376R
|
10.2 mM (72h, 2DG monotherapy)
|
sulforhodamine B assay
|
Download PDF
|
|
Vero cells
|
1 mM (E gene, supernatant), 0.6 mM (RdRp gene, cell-bound)
|
RT-PCR (viral E and RdRp genes)
|
PMC8847085
|
|
H508
|
6.48 mM
|
ATP bioluminescence cell viability assay
|
Download PDF
|
|
293T-GLUT5
|
1.75 mM
|
ATP bioluminescence cell viability assay
|
Download PDF
|
|
293T KO2-GLUT5
|
0.550 mM
|
ATP bioluminescence cell viability assay
|
Download PDF
|
|
Trained PC3
|
0.0931 mM
|
ATP bioluminescence cell viability assay
|
Download PDF
|
|
Trained PC3
|
1.75 mM
|
ATP bioluminescence cell viability assay
|
Download PDF
|
|
U-87
|
20 mM (48 h), 5 mM (72 h)
|
MTS assay
|
Download PDF
|
|
U-251
|
12 mM (48 h), 5 mM (72 h)
|
MTS assay
|
Download PDF
|
|
3417 (Mut-m1)
|
10.2 ± 0.8 mM
|
Live-cell imaging and crystal violet for cell density; IC50 analyzed in Prism
|
PMC7649750
|
|
3418 (Mut-m2)
|
12.1 ± 1.1 mM
|
Live-cell imaging and crystal violet for cell density; IC50 analyzed in Prism
|
PMC7649750
|
|
300 (WT-m1)
|
28.1 ± 2.1 mM
|
Live-cell imaging and crystal violet for cell density; IC50 analyzed in Prism
|
PMC7649750
|
|
5770 (WT-m2)
|
29.8 ± 2.3 mM
|
Live-cell imaging and crystal violet for cell density; IC50 analyzed in Prism
|
PMC7649750
|
|
SKMEL-24 (Mut-h1)
|
11.5 ± 0.9 mM
|
Live-cell imaging and crystal violet for cell density; IC50 analyzed in Prism
|
PMC7649750
|
|
WM278 (Mut-h2)
|
13.2 ± 1.2 mM
|
Live-cell imaging and crystal violet for cell density; IC50 analyzed in Prism
|
PMC7649750
|
|
A375 (WT-h1)
|
30.1 ± 2.5 mM
|
Live-cell imaging and crystal violet for cell density; IC50 analyzed in Prism
|
PMC7649750
|
|
RPMI-7951 (WT-h2)
|
32.5 ± 2.8 mM
|
Live-cell imaging and crystal violet for cell density; IC50 analyzed in Prism
|
PMC7649750
|
|
4T1
|
5.53 mmol/L
|
Cell counting Kit-8
|
Download PDF
|
|
MCF-7
|
8.67 mmol/L
|
Cell counting Kit-8
|
Download PDF
|
|
cystic epithelial cells
|
30.9 mM
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
NSCLC NCI-H1299 (KS)
|
0.8412 mM
|
MTS assay
|
Download PDF
|
|
NSCLC NCI-H1299 (K)
|
1.496 mM
|
MTS assay
|
Download PDF
|
|
NSCLC NCI-H1299 (S)
|
2.472 mM
|
MTS assay
|
Download PDF
|
|
NSCLC NCI-H1299 (WT)
|
3.461 mM
|
MTS assay
|
Download PDF
|
|
BJAB
|
4.65 mM
|
MTT assay
|
Download PDF
|
|
OCI-LY3
|
4.073 mM
|
MTT assay
|
Download PDF
|
|
SU-DHL-6
|
2.86 mM
|
MTT assay
|
Download PDF
|
|
SMMC-7721
|
358.5 μM
|
MTT method
|
Download PDF
|
|
SMMC-7721/DOX
|
643.6 μM
|
MTT method
|
Download PDF
|
|
MCF7 cells
|
10 mM
|
mammosphere formation
|
Download PDF
|
|
MDA-MB-231
|
2.03 mM
|
Hoechst DNA content assay
|
Download PDF
|
|
MDA-Ets1KD
|
3.94 mM
|
Hoechst DNA content assay
|
Download PDF
|